Figure 5.

PU-H71 induces ubiquitination and proteasomal degradation of STK33. (a) Immunoblot of A549 cells treated with 20 mM NH4Cl for 2 h, followed by incubation with 0.5 µM PU-H71 for 16 h. One of two independent experiments is shown. (b) Immunoblot of A549 cells treated with 10 µM MG-132 for 2 h, followed by incubation with 0.5 µM PU-H71 for 16 h. (c) IP of HA-tagged STK33 from 293T cells treated with or without 1 µM PU-H71 for 7 h and 10 µM MG-132 for the final 3 h. Ubiquitinated STK33 appears as a smear with high molecular weight. One of three independent experiments is shown. (d) Anti-Flag IPs were performed with KRAS WT BT-20 and mutant KRAS-dependent MDA-MB-231 cells stably transduced with empty vector (EV), N-terminally Flag-tagged STK33 (Flag-STK33), or C-terminally Flag-tagged STK33 (STK33-Flag), and the resulting protein complexes were analyzed by mass spectrometry. The enrichment of peptides representing proteins involved in the ubiquitin/proteasome system is shown. (e) Immunoblot of MDA-MB-231 and A549 cells transduced with empty vector (EV) or BAG2 and treated with 0.5 µM PU-H71 for 24 h. (f) Immunoblot of HCT-116 and A549 cells transduced with a nontargeting control shRNA or shRNAs targeting BAG2. (g) Anti-Flag IPs were performed with MDA-MB-231 cells stably transduced with empty vector (EV) or Flag-tagged STK33, and immunoblots were probed with antibodies against BAG2 and Flag. One of two independent experiments is shown. (h) Immunoblot of 293T cells transfected with HA-tagged STK33 or Xpress-tagged USP15 and USP5, respectively, and treated with or without 0.5 µM PU-H71 for 24 h. One of two independent experiments is shown. (i) MDA-MB-231 cells were transfected with a nontargeting control shRNA or a shRNA targeting HERC2. After 3 d, cells were incubated with 1 µM PU-H71 for 18 h, as indicated. Protein levels were analyzed by Western blotting using the indicated antibodies. One of two independent experiments is shown.

or Create an Account

Close Modal
Close Modal